Bipolar disorder Events Pharmaceuticals 
Mad in America
JULY 13, 2024
The technique of excluding trials with ‘zero events’ is problematic, however, because it excludes much relevant data and makes suicide seem more common than it is. Then Martin Plöderl joined the team and brought expertise in new statistical methods of meta-analysis that have been developed to manage ‘zero event’ trials.
Mad in America
NOVEMBER 7, 2023
For example, the “availability” shortcut: if an example of a particular event comes quickly to mind, we think the event is common; whereas if an example is hard to find in memory, we think the event is rare. This obviously leads to errors when the event is striking and dramatic (e.g. treatment-resistant tuberculosis).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
JANUARY 4, 2025
In our 2015 book Psychiatry Under the Influence , Lisa Cosgrove and I wrote about the STAR*D scandal in depth, as it served as an example of the institutional corruption in psychiatry due to pharmaceutical interests and psychiatrys own guild interests. The 12 STAR*D authors listed a collective total of 151 ties to pharmaceutical companies.
Mad in America
JANUARY 9, 2024
Academics even boast that EBM shackles the pharmaceutical industry. A century ago, Paul Ehrlich, whose research helped create the modern pharmaceutical industry, saw the ideal medicine as a Magic Bullet, a drug that hits a target without causing collateral damage. Doctors adamantly insist they are not influenced by adverts.
Mad in America
NOVEMBER 6, 2024
Dhar: Eventually you found the trauma model that talked about extreme childhood stress events, and it explained a lot of your suffering. You write that you worry about how psychedelics are getting co-opted by pharmaceutical industries. There wasn’t much space for another way of seeing the problem of obsessions and compulsions.
Mad in America
MARCH 15, 2025
This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). accepting personal or office gifts or corporate donations from industry.
Mad in America
OCTOBER 10, 2023
With the explosion of more and more drugs in cabinets across the country, more and more children are dying—but still, pharmaceutical companies push their products, leading to yet more drugs and yet more deaths. Unlike the pharmaceutical industry, in our village community the pain of losing a single child was felt by all.
Expert insights. Personalized for you.
144 
Let's personalize your content